Marc Iskowitz MM+M - Medical Marketing and Media - Page 2 of 135

Marc Iskowitz

Most recent articles by Marc Iskowitz

Pfizer CEO on battling virus, tackling new variants and eventual vindication
Pfizer CEO on battling virus, tackling new variants and eventual vindication
Marc Iskowitz
February 5, 2021
12:41 pm

Albert Bourla shared why he has yet to receive his company’s coronavirus vaccine and more in a virtual appearance Thursday.

As docs grow irritated with their digital outreach, pharmas see imperative to fix pain points
As docs grow irritated with their digital outreach, pharmas see imperative to fix pain points
Marc Iskowitz
January 29, 2021
1:24 pm

Could this finally be the ‘dawning of experience’ in life sciences?

Virtual selling proved its mettle in 2020
Virtual selling proved its mettle in 2020
Marc Iskowitz
January 27, 2021
9:46 am

Where does that leave pharma’s armies of reps?

How pharma brands handled paid social during Trump’s final 2 weeks in office
How pharma brands handled paid social during Trump’s final 2 weeks in office
Marc Iskowitz
January 22, 2021
3:01 pm

Some brands that paused Twitter ads after the Capitol riot have yet to return.

W2O plucks a rival’s digital chief, two other tech vets
W2O plucks a rival’s digital chief, two other tech vets
Marc Iskowitz
January 22, 2021
9:01 am

Saitta, Mickelberg and Mendell further bolster the agency’s health-tech business.

Until we meet again: Reflections from a JPMorgan Health Conference like no other
Until we meet again: Reflections from a JPMorgan Health Conference like no other
Marc Iskowitz
January 15, 2021
10:30 am

There were pluses and minuses to attending from afar.

Pharmacies take center stage at day three of JPM
Pharmacies take center stage at day three of JPM
Marc Iskowitz
January 14, 2021
5:00 am

Every crisis has its winners and losers, and this once-in-a-generation pandemic is no exception.

Behavioral scientists propose fixes for the ailing vaccine rollout
Behavioral scientists propose fixes for the ailing vaccine rollout
Marc Iskowitz
January 12, 2021
12:34 pm

Sacrificing equity for vaccine expediency is a bad idea, behavioral-science experts warn.

What Zoom fatigue? Day one at virtual JPM 2021 sees vaccine updates vying for airtime
What Zoom fatigue? Day one at virtual JPM 2021 sees vaccine updates vying for airtime
Marc Iskowitz
January 11, 2021
10:00 pm

In their presentations, BioNTech, J&J and Novavax execs offered glimpses of the road ahead.

Five things for pharma marketers to know: Tuesday, December 29, 2020
Five things for pharma marketers to know: Tuesday, December 29, 2020
Marc Iskowitz
December 29, 2020
5:00 am

AZ CEO talks up COVID-19 shot ahead of U.K. approval; Report: I.D. docs’ ‘lukewarm response’ stunts rollout of mAb therapies for coronavirus; Regulatory issues in store for Madison Ave. include taxes on ads.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners